Search results for " function"

showing 10 items of 9395 documents

Inter- and intra-individual variability of paired-pulse curves with transcranial magnetic stimulation (TMS).

2002

Objectives: Previous studies have evaluated the variability of motor thresholds (MTs) and amplitude of motor-evoked potentials (MEPs) to transcranial magnetic stimulation (TMS) within and across individuals. Here we evaluate the reproducibility and inter-hemispheric variability of measures of cortical excitability using the 'conventional' paired-pulse (PP) TMS technique. Methods: We studied PP curves of the left and right hemisphere in 10 healthy subjects on two separate days 2 weeks apart. The inter-stimulus intervals studied were 1, 3, 6, 8, 10 and 12 ms with the conditioning stimulus being 80% of the resting MT, and a single test stimulus producing MEPs of approximately 0.8 mV peak-to-pe…

AdultMalemedicine.medical_specialtyTime Factorsmedicine.medical_treatmentNeurophysiologyAudiologyStimulus (physiology)Lateralization of brain functionElectromagnetic FieldsPhysiology (medical)medicineHumansHealthy subjectsDominance CerebralObserver VariationReproducibilityMotor CortexMotor controlReproducibility of ResultsCortical excitabilityPaired-pulseNeurophysiologyMiddle AgedEvoked Potentials MotorSensory SystemsElectric StimulationTranscranial magnetic stimulationmedicine.anatomical_structureNeurologySensory ThresholdsLateralityFemaleNeurology (clinical)PsychologyNeuroscienceTranscranial magnetic stimulationMotor cortexClinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology
researchProduct

Crucial Role of Extended Criteria Donors in Deceased Donor Single Kidney Transplantation to Face Chronic Shortage in the Heart of the Mediterranean B…

2019

Background: The gap between organ availability and patients on the waiting list for deceased donor kidney transplants has resulted in the wide use of extended criteria donors (ECDs).We aimed to compare the surgical outcomes of single kidney transplantation (KT) performed at our institute with standard criteria donor (SCD) or ECD grafts, according to the Organ Procurement and Transplantation Network definition. Patients and methods. Our retrospective analysis studied 115 adult recipients of KT from January 2016 to July 2018, with kidney grafts procured from adult donors after brain or circulatory death, performed at our institute. Among the 2 recipients’ groups, we compared the incidence of …

AdultMalemedicine.medical_specialtyTissue and Organ ProcurementDelayed Graft FunctionSingle CenterMedicineHumansSurvival analysisKidney transplantationRetrospective StudiesTransplantationKidneyContinental Population Groupsbusiness.industryIncidence (epidemiology)IncidenceGraft SurvivalRacial GroupsRetrospective cohort studyMiddle Agedmedicine.diseaseKidney TransplantationSurvival AnalysisTissue DonorsSurgeryTransplantationsurgical procedures operativemedicine.anatomical_structureTreatment OutcomeSurgeryFemalebusinessBody mass indexTransplantation proceedings
researchProduct

Variation of serum and urinary neutrophil gelatinase associated lipocalin (NGAL) after strenuous physical exercise.

2012

AbstractStrenuous exercise may trigger acute complications, such as exertional rhabdomyolysis and gastrointestinal complaint. As less is known about the potential renal impairment after long distance running, we assessed creatinine and neutrophil gelatinase associated lipocalin (NGAL) in serum (sNGAL) and urine (uNGAL) before and after an ultramarathon.The study population consisted of 16 trained male athletes who ran a 60 km ultramarathon. Blood and spot urine samples were collected 20 min before and immediately after the run. Creatinine was assessed by Jaffe assay on Beckman Coulter AU5800 and renal function was expressed as estimated glomerular filtration rate (eGFR) by MDRD formula. NGA…

AdultMalemedicine.medical_specialtyUrinary systemClinical BiochemistryUrologyRenal functionPhysical exerciseUrineCreatinine; neutrophil gelatinase associated lipocalin (NGAL); physical exercise; sportsLipocalinchemistry.chemical_compoundLipocalin-2physical exerciseProto-Oncogene ProteinsmedicineHumansExerciseCreatininebusiness.industryBiochemistry (medical)Acute kidney injuryneutrophil gelatinase associated lipocalin (NGAL)General MedicineAcute Kidney InjuryMiddle Agedmedicine.diseaseLipocalinschemistryCreatinineExertional rhabdomyolysissportsbusinessAcute-Phase ProteinsGlomerular Filtration RateClinical chemistry and laboratory medicine
researchProduct

Blood and urinary abnormalities induced during and after 24-hour continuous running: A case report

2016

In this reported clinical case, a healthy and well-trained male subject [aged 37 years, maximal oxygen uptake (V[Combining Dot Above]O2max) 64 mL·kg·min] ran for 23 hours and 35 minutes covering 160 km (6.7 km/h average running speed). The analysis of hematological and biochemical parameters 3 days before the event, just after termination of exercise, and after 24 and 48 hours of recovery revealed important changes on muscle and liver function, and hemolysis. The analysis of urine sediments showed an increment of red and white blood cells filtrations, compatible with transient nephritis. After 48 hours, most of these alterations were recovered. Physicians and health professionals who monito…

AdultMalemedicine.medical_specialtyUrinary systemPhysiologyPhysical Therapy Sports Therapy and RehabilitationUrine030204 cardiovascular system & hematologyHemolysisRunning03 medical and health sciences0302 clinical medicineAtletamedicineHumansOrthopedics and Sports MedicineMuscle SkeletalPathologicalNephritisbusiness.industryMedicina deportivaVO2 max030229 sport sciencesAtletasmedicine.diseaseHemolysisSurgeryLiverClinical caseLiver functionbusinessNephritisBiomarkers
researchProduct

Long-term urinary dysfunction after mesorectal excision: a prospective study with intraoperative electrophysiological confirmation of nerve preservat…

2006

Bladder dysfunctions are well-recognized complications after nerve-sparing mesorectal excision for rectal cancer. This study sought to symptomatically analyze the extent of recovery from major and minor urinary symptoms in patients with signs of bladder denervation.Sixty-two patients with mesorectal excision for rectal cancer were investigated prospectively. Pelvic autonomic nerve preservation (PANP) was assessed macroscopically and with the aid of intraoperative electrical stimulation of pelvic autonomic nerves (INS). Bladder function was evaluated with the International Prostate Symptom Score (IPSS) and the Quality of life index (Qol). Median follow-up was 20 months (range 3-40 months).Fo…

AdultMalemedicine.medical_specialtyUrinary systemUrinary BladderElectric Stimulation Therapyurologic and male genital diseasesQuality of lifeParasympathetic Nervous SystemMonitoring IntraoperativemedicineHumansProspective StudiesProspective cohort studyNeurogenic bladder dysfunctionMesorectalAgedAged 80 and overbusiness.industryRectal NeoplasmsRectumGeneral MedicineMiddle AgedUrinary functionmedicine.diseaseSurgeryTreatment OutcomeUrinary IncontinenceOncologyQuality of LifeSurgeryInternational Prostate Symptom ScoreFemaleComplicationbusinessFollow-Up StudiesEuropean journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology
researchProduct

Two yr mycophenolate mofetil plus low-dose calcineurin inhibitor for renal dysfunction after liver transplant

2009

We assessed the efficacy and outcome of low through level of calcineurin inhibitors (CNI) and introducing mycophenolate mofetil (MMF) in liver transplant (LT) patients with CNI-related renal dysfunction. Thirty LT patients were converted to combined therapy and compared with 30 patients used as a contemporary control group receiving CNI only. The two groups were matched for sex, age, months after LT, immunosuppressive treatment, creatinine level, presence of diabetes and calculated glomerular filtration rate (GFR) via Cockroft-Gault method. After two years, in the MMF serum creatinine decreased from 1.65 mg/dL (range 1.33-3.5) to 1.4 mg/dL (range 0.9-4.7) (p = 0.002) and GFR increased from …

AdultMalemedicine.medical_specialtyUrinary systemmedicine.medical_treatmentCalcineurin InhibitorsUrologyRENAL DYSFUNCTIONRenal functionCALCINEURIN INHIBITORS; IMMUNOSUPPRESSION; LIVER TRANSPLANTATION; MYCOPHENOLATE MOFETIL; RENAL DYSFUNCTIONLiver transplantationKidney Function TestsTacrolimusMycophenolic acidNephrotoxicitychemistry.chemical_compoundmedicineHumansMYCOPHENOLATE MOFETILAgedTransplantationCreatinineIMMUNOSUPPRESSIONDose-Response Relationship Drugbusiness.industryGraft SurvivalMiddle AgedMycophenolic AcidTacrolimusLiver TransplantationCalcineurinliver transplantTreatment OutcomechemistryCreatinineImmunologyKidney Failure ChronicDrug Therapy CombinationFemalebusinessImmunosuppressive AgentsGlomerular Filtration Ratemedicine.drug
researchProduct

Pharmacokinetics of atenolol in relation to renal function

1981

The plasma levels and urinary excretion of carteolol and its main metabolites 8-hydroxycarteolol and carteolol glucuronide were investigated in 6 healthy subjects and 9 patients with varying degrees of renal impairment following a single oral dose of 30 mg carteolol hydrochloride. In healthy subjects the half-life of carteolol was 7.1 h. 63% of the administered dose was recovered unchanged in urine, and in all 84% was excreted by the kidneys. The renal clearance of carteolol was 255 ml/min. In chronic renal failure (CRF) the terminal half-life was increased to a maximum of 41 h. Both the elimination rate constant and renal clearance were closely related to the creatinine clearance. In CRF t…

AdultMalemedicine.medical_specialtyUrologyAdministration OralRenal functionCarteolol HydrochloridePropanolamineschemistry.chemical_compoundPharmacokineticsElimination rate constantRenal DialysisInternal medicinemedicineHumansPharmacology (medical)CarteololAgedPharmacologyKidneyCreatinineMaintenance dosebusiness.industryGeneral MedicineMiddle AgedKineticsEndocrinologymedicine.anatomical_structureAtenololchemistryInjections IntravenousFemaleKidney DiseasesbusinessGlomerular Filtration Ratemedicine.drugEuropean Journal of Clinical Pharmacology
researchProduct

Enzyme replacement therapy with agalsidase alfa in patients with Fabry's disease: an analysis of registry data

2009

Summary Background We analysed 5-year treatment with agalsidase alfa enzyme replacement therapy in patients with Fabry's disease who were enrolled in the Fabry Outcome Survey observational database (FOS). Methods Baseline and 5-year data were available for up to 181 adults (126 men) in FOS. Serial data for cardiac mass and function, renal function, pain, and quality of life were assessed. Safety and sensitivity analyses were done in patients with baseline and at least one relevant follow-up measurement during the 5 years (n=555 and n=475, respectively). Findings In patients with baseline cardiac hypertrophy, treatment resulted in a sustained reduction in left ventricular mass (LVM) index af…

AdultMalemedicine.medical_specialtyUrologyRenal functionKidney Function TestsMuscle hypertrophyQuality of lifeSurveys and QuestionnairesEpidemiologymedicineHumansRegistriesPain MeasurementVascular diseasebusiness.industryGeneral MedicineEnzyme replacement therapymedicine.diseaseFabry's diseaseFabry diseaseRecombinant ProteinsSurgeryIsoenzymesTreatment Outcomealpha-GalactosidaseHeart Function TestsQuality of LifeFabry DiseaseFemalebusinessThe Lancet
researchProduct

The effect of cholecalciferol for lowering albuminuria in chronic kidney disease: a prospective controlled study.

2013

Background. Growing evidence indicates that vitamin D receptor activation may have antiproteinuric effects. We aimed to evaluate whether vitamin D supplementation with daily cholecalciferol could reduce albuminuria in proteinuric chronic kidney disease (CKD) patients. Methods. This 6-month prospective, controlled, intervention study enrolled 101 non-dialysis CKD patients with albuminuria. Patients with low 25(OH) vitamin D [25(OH)D] and high parathyroid hormone (PTH) levels (n = 50; 49%) received oral cholecalciferol (666 IU/day), whereas those without hyperparathyroidism (n = 51; 51%), independent of their vitamin D status, did not receive any cholecalciferol, and were considered as the co…

AdultMalemedicine.medical_specialtyUrologyRenal functionParathyroid hormoneAdministration OralCalcitriol receptorPhosphateschemistry.chemical_compoundYoung AdultChronic kidney diseaseEstadística e Investigación OperativaInternal medicinemedicineVitamin D and neurologyAlbuminuriaHumansProspective StudiesRenal Insufficiency ChronicVitamin DAgedCholecalciferolAged 80 and overTransplantationHyperparathyroidismbusiness.industryHyperparathyroidismVitaminsMiddle Agedmedicine.diseaseVitamin D DeficiencyEndocrinologychemistryNephrologyParathyroid HormoneDietary SupplementsAlbuminuriaDisease ProgressionFemalemedicine.symptomCholecalciferolbusinessKidney diseaseNephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association
researchProduct

Pulmonary embolism location is associated with the co-existence of the deep venous thrombosis.

2019

Multiple studies have shown that in approximately half of individuals with pulmonary embolism (PE), the deep venous thrombosis (DVT) is not evident at the moment of PE diagnosis. The underlying factors and the origin of PE in these patients are not completely understood: missed DVT, embolization of DVT in its entirety, or de-novo PE being possible explanations. The aim of this study was to evaluate the differences in PE patient with or without co-existing DVT. Sixty-three consecutive PE patients were included. Whole leg bilateral Doppler compression ultrasound was performed to all patients. The PE location and extension, C-reactive protein, platelet count, hemostatic markers FV, FVIII, FXII…

AdultMalemedicine.medical_specialtyVEIN THROMBOSISmedicine.medical_treatment030204 cardiovascular system & hematologyFibrinogenPulmonary function testing03 medical and health sciencesTHROMBOEMBOLISM0302 clinical medicineInternal medicineSCOREmedicineFactor V LeidenFACTOR-V-LEIDENHumanscardiovascular diseasesEmbolizationProspective Studiescoagulationhemostatic markersProspective cohort studydeep venous thrombosisAgedRISKVenous ThrombosisHemostasisLegbusiness.industryUltrasonography DopplerHematologyGeneral MedicineNITRIC-OXIDE MEASUREMENTSMiddle Agedmedicine.disease3. Good healthPulmonary embolismVenous thrombosis3121 General medicine internal medicine and other clinical medicineHemostasisisolated pulmonary embolismCardiologyFemalebusinessPulmonary Embolism030215 immunologymedicine.drugBlood coagulationfibrinolysis : an international journal in haemostasis and thrombosis
researchProduct